Key takeaway Specific probiotic strains such as Saccharomyces boulardii and Bifidobacterium lactis BB-12 can offer a supportive approach to managing GI side effects associated with GLP-1 receptor agonists
Tirzepatide (Mounjaro) dual GIP/GLP-1 receptor agonist) 3,4 3,4 Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that produces superior weight loss compared with selective GLP-1 receptor agonists, through: Enhanced appetite suppression via dual receptor activation
Tylenol (acetaminophen) is one of the most commonly used painkillers, but it comes with side effects
Standard maintenance: - Type I-II: 0.5 mg twice per week - Type III-IV: 0.5 mg once per week - Type V-VI: 0.5 mg every 2-3 weeks Alternative approach: Some users prefer a single larger weekly dose (1.0 mg once per week instead of 0.5 mg twice per week)
Patients should discuss any concerns about sexual function changes with their healthcare provider, who can: Conduct comprehensive health assessments Monitor side effects Adjust treatment plans as needed Discussing changes with intimate partners helps: Prevent misunderstandings Explore alternative forms of intimacy Develop shared solutions for maintaining connection When implemented together, these approaches provide a comprehensive strategy for managing libido changes while continuing Ozempic treatment
We do not anchor success on the day-one mirror impression because day-one is dominated by swelling, anaesthesia residue, and patient excitement or anxiety